Genome-wide discovery of circulating cell-free DNA methylation signatures for the differential diagnosis of triple-negative breast cancer.

Although cg23247845 methylation levels did not reach statistical significance, likely due to limited sample sizes, incorporating both markers into the cf-MDS, which could significantly distinguish TNBC from non-TNBC patients.

also in 111,027 other papers